A meta-analysis of 21 double-blind clinical trials concluded that acetyl-L-carnitine treatment in patients with mild cognitive impairment and mild Alzheimer's disease demonstrated significant efficacy versus placebo in improving cognitive function, particularly in domains of logical intelligence, verbal memory, selective attention, and functional capacity
[Abstract]2022 Aug 22;2022:5936753
Approximately 530,000 compounds from the Asinex library and 130,000 compounds from the ZINC natural products library were used
39 DTC-GT assesses inherited disease risks and has received recent approvals from the Food and Drug Administration as depicted in Figure 5
Cagrilintide Monotherapy (Representative Research Pattern): Cagrilintide in Combination Therapy (e.g., with Semaglutide - CagriSema): Trials investigating combinations like CagriSema use specific dose levels of each component, also typically involving escalation schedules for both peptides